Products Categories
CAS No.: | 63516-07-4 |
---|---|
Name: | Flutropium bromide |
Molecular Structure: | |
|
|
Formula: | C24H29BrFNO3 |
Molecular Weight: | 496.47 |
Synonyms: | Flutropium Bromide;Flutropium;8-Azoniabicyclo[3.2.1]Octane, 8-(2-Fluoroethyl)-3-[(Hydroxydiphenylacetyl)Oxy]-8-Methyl-, Bromide, (3-Endo,8-Syn)-;8-Azoniabicyclo[3.2.1]Octane, 8-(2-Fluoroethyl)-3-[(Hydroxydiphenylacetyl)Oxy]-8-Methyl-, Bromide, (Endo,Syn)-;Ba 598br;Flubron;Ba 598;Flutropiumbromid; |
EINECS: | 1533716-785-6 |
Melting Point: | 192-193° (dec); mp 198-199° (dec) |
Safety: | Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion and subcutaneous routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx, Br−, and Cl−. |
PSA: | 46.53000 |
LogP: | 0.53800 |
Chemistry informtion about Flutropium Bromide Hydrate (CAS NO.63516-07-4) is:
IUPAC Name: Acetyloxy-[5'-(Acetyloxymercurio)-3',6'-Dihydroxy-3-Oxospiro[2-Benzofuran-1,9'-Xanthene]-4'-Yl]Mercury
Synonyms: Flutropium Bromide ; Flutropium ; 8-Azoniabicyclo[3.2.1]Octane, 8-(2-Fluoroethyl)-3-[(Hydroxydiphenylacetyl)Oxy]-8-Methyl-, Bromide, (3-Endo,8-Syn)- ; 8-Azoniabicyclo[3.2.1]Octane, 8-(2-Fluoroethyl)-3-[(Hydroxydiphenylacetyl)Oxy]-8-Methyl-, Bromide, (Endo,Syn)- ; Ba 598br ; Flubron ; Ba 598 ; Flutropiumbromid
Molecular Formula: C24H29BrFNO3
Molecular Weight: 478.39
Following is the molecular structure of Flutropium Bromide Hydrate (CAS NO.63516-07-4) is:
Flutropium Bromide Hydrate (CAS NO.63516-07-4) is a quaternary ammonium antimuscarinic with bronchodilator properties that has been tried in the treatment of respiratory-tract.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 53mg/kg (53mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 735, 1988. | |
mouse | LD50 | intravenous | 11mg/kg (11mg/kg) | behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea behavioral: ataxia | Arzneimittel-Forschung. Drug Research. Vol. 36, Pg. 1348, 1986. |
mouse | LD50 | oral | 760mg/kg (760mg/kg) | behavioral: convulsions or effect on seizure threshold behavioral: ataxia lungs, thorax, or respiration: dyspnea | Arzneimittel-Forschung. Drug Research. Vol. 36, Pg. 1348, 1986. |
mouse | LD50 | subcutaneous | 228mg/kg (228mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 735, 1988. | |
rat | LD50 | intraperitoneal | 77mg/kg (77mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 735, 1988. | |
rat | LD50 | intravenous | 12500ug/kg (12.5mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 735, 1988. | |
rat | LD50 | oral | 740mg/kg (740mg/kg) | behavioral: convulsions or effect on seizure threshold behavioral: ataxia lungs, thorax, or respiration: dyspnea | Arzneimittel-Forschung. Drug Research. Vol. 36, Pg. 1348, 1986. |
rat | LD50 | subcutaneous | 615mg/kg (615mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 735, 1988. |
Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion and subcutaneous routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx, Br−, and Cl−.